Astera Labs (ALAB) valuation
Astera Labs P/E ratio history
Astera Labs trades at 128.1 times its earnings over the last twelve months and 49.6 times the earnings analysts expect over the next twelve.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $166.36 | $1.22 | 136.4 | 74.8 |
| Dec 31, 2024 | $132.45 | -$0.64 | n/m | 125.2 |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Astera Labs valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Astera LabsALAB | $44.3B | 128.1 | 49.6 | 36.9 |
| Microchip TechnologyMCHP | $41.9B | 113.7 | 19.9 | 8.2 |
| Monolithic Power SystemsMPWR | $59.5B | 74.0 | 30.8 | 18.2 |
| NXP SemiconductorsNXPI | $65.5B | 20.4 | 14.8 | 4.7 |
| Credo TechnologyCRDO | $28.2B | 53.2 | 21.0 | 17.7 |
| ON SemiconductorON | $28.1B | 47.5 | 18.4 | 4.5 |
| First SolarFSLR | $18.7B | 10.1 | 8.0 | 3.7 |
| Skyworks SolutionsSWKS | $13.2B | 45.1 | 15.6 | 3.3 |
| Marvell TechnologyMRVL | $172B | 65.0 | 34.0 | 18.2 |
| Peer median | 50.3 | 19.1 | 6.5 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ALAB financials · ALAB returns
No forecast, no recommendation. This page describes Astera Labs from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.